An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling
Cells · 2024
DOI: 10.3390/cells13151258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Ana Limerick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: Cilia, Hedgehog Proteins, Signal Transduction, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Mutations in human CILK1 (ciliogenesis associated kinase 1) are linked to ciliopathies and epilepsy. Homozygous point and nonsense mutations that extinguish kinase activity impair primary cilia function, whereas mutations outside the kinase domain are not well understood. Here, we produced a knock-in mouse equivalent to the human CILK1 A615T variant identified in juvenile myoclonic epilepsy (JME). This residue is in the intrinsically disordered C-terminal region of CILK1 separate from the kinase domain. Mouse embryo fibroblasts (MEFs) with either heterozygous or homozygous A612T mutant alleles exhibited a higher ciliation rate, shorter individual cilia, and upregulation of ciliary Hedgehog signaling. Thus, a single A612T mutant allele was sufficient to impair primary cilia and ciliary signaling in MEFs. Gene expression profiles of wild-type versus mutant MEFs revealed profound changes in cilia-related molecular functions and biological processes. The CILK1 A615T mutant protein was not increased to the same level as the wild-type protein when co-expressed with scaffold protein KATNIP (katanin-interacting protein). Our data show that KATNIP regulation of a JME-associated single-residue variant of CILK1 is compromised, and this impairs the maintenance of primary cilia and Hedgehog signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA.
ORCID-Profile: Kevin W Kuang, David L Brautigan, Zheng Fu
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Cancer Institute, Cancer Center
- UVA College Council
Zitieren
APA
Limerick, A., McCabe, E. A., Turner, J. S., Kuang, K. W., Brautigan, D. L., Hao, Y., Chu, C. Y., Fu, S. H., Ahmadi, S., Xu, W., & Fu, Z. (2024). An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling. Cells. https://doi.org/10.3390/cells13151258
Vancouver
Limerick A, McCabe EA, Turner JS, Kuang KW, Brautigan DL, Hao Y, et al. An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling. Cells. 2024. doi:10.3390/cells13151258
BibTeX
@article{Limerick2024,
author = {Limerick, Ana and McCabe, Ellie A and Turner, Jacob S and Kuang, Kevin W and Brautigan, David L and Hao, Yi and Chu, Cheuk Ying and Fu, Sean H and Ahmadi, Sean and Xu, Wenhao and Fu, Zheng},
title = {An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13151258}
}
EUVIMED